Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Gabriela Oliveira

Has grant

Universidade Federal de São Carlos

Brazil

Research Interests

Explore related searches

Professors in Immunology

Recent Grants

Grant: Close

Associate researcher, phase I/II clinical research – with the project “Effects of immunotherapy with Oncotherad® (MRB-CFI-1) in the treatment of patients with recurrent non-muscle invasive bladder cancer undergoing therapy with Bacillus calmette-guérin (BCG) and/or intravesical chemotherapy”

Open Date: 2024-01-01

Close Date:

Grant: Close

Comparative Study of Immunotherapeutic Treatments for Chemically Induced Ovarian Cancer in Rats

Open Date: 2021-01-01

Close Date: 2023-01-01

Grant: Close

Desenvolvimento de luciferases emissoras de luz vermelha termoestáveis de Phrixotrix hirtus para finalidades bioanalíticas: relação estrutura e função

Open Date:

Close Date:

Articles (7)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (3)

Wagner José Fávaro

Assistant Professor and Researcher

University of Campinas

BRAZIL

View details

Cristina Ribeiro de Barros Cardoso

Associate Professor

University of Sao Paulo

BRAZIL

View details

Nelson Durán

Full professor

University of Campinas

BRAZIL

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gabriela Oliveira

Research Interests

Explore related searches

Recent Grants

Articles (7)

A novel serous ovarian carcinoma model induced by DMBA: Results from OncoTherad® (MRB-CFI-1) immunotherapy preclinical testing

From Bench to Bedside in the Global South: OncoTherad (MRB-CFI-1) Experience as Scalable and Cost-Effective Model for Nanoimmunotherapy Development

Modulation of the tumor microenvironment in non-muscle-invasive bladder cancer by OncoTherad® (MRB-CFI-1) nanoimmunotherapy: effects on tumor-associated macrophages, tumor-infiltrating lymphocytes, and monoamine oxidases

Profiling energy metabolism in normal bladder tissue and non-muscle-invasive bladder cancer cases of different histological grades

A novel therapeutic strategy for non-muscle invasive bladder cancer: OncoTherad® immunotherapy associated with platelet-rich plasma

Clinical implications of T-Cells CX3CR1+, Toll-like Receptor 4 signaling pathway, and immune checkpoints in Non-Muscle Invasive Bladder Cancer

New synthetic nano-immunotherapy (OncoTherad®) for non-muscle invasive bladder cancer: Its synthesis, characterization and anticancer property

Collaborators (3)

Wagner José Fávaro

Cristina Ribeiro de Barros Cardoso

Nelson Durán

Make your next move.